Home › NDC Lookup › Ingredients › Octinoxate › 82715-0107-09
GR LONGSTAY Matte Face Powder SPF 15 Octinoxate 1.995 g/100g Powder, 12.7 g — NDC 82715-0107-09 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

GR LONGSTAY Matte Face Powder SPF 15 Octinoxate 1.995 g/100g Powder, 12.7 g — NDC 82715-107-09 (Billing 82715-0107-09)

by ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI · 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER

This is a package of 12.7 g of GR LONGSTAY Matte Face Powder SPF 15 Octinoxate 1.995 g/100g Powder from ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI, marketed since Jul 2022 and currently FDA-listed, this package's marketing is listed to end Apr 2029.

NDC 82715-0107-09
🏷️ FDA NDC (as labeled) 82715-107-09 billing pads the product segment with a zero
This package
Contains12.7 g Pack sizes10 compare ↓
Product page 82715-0107-01 Also comes in: 12.7 g 82715-107-01 12.7 g 82715-107-02 12.7 g 82715-107-03 12.7 g 82715-107-04 12.7 g 82715-107-05 12.7 g 82715-107-06 12.7 g 82715-107-07 12.7 g 82715-107-08 12.7 g 82715-107-10
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 82715-107-09 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
82715 labeler · 107 product · 09 package
Package marketed since
Jul 22, 2022
Package marketing ended
Apr 30, 2029
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 8271510709 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 82715-107-09
Product NDC 82715-107
11-digit billing NDC 82715010709
UNII 4Y5P7MUD51
Application # M020
SPL Set ID 62759398-4935-4732-b950-cfbeab82bc5a
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-07-22
Marketing end 2029-04-30
Route TOPICAL
Dosage form POWDER
Substance OCTINOXATE
Why two NDCs? The FDA registers this code as 82715-107-09 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82715-0107-09. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

GR LONGSTAY Matte Face Powder SPF 15 is a topical powder product that contains octinoxate, a sunscreen ingredient. Octinoxate is an ultraviolet (UV) filter commonly used in sunscreen and cosmetic products to help protect skin from sun exposure. This is an over-the-counter monograph drug, meaning it is marketed under FDA's established rules for sunscreen products rather than as an individually approved application. The powder form is applied directly to the face.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12.7 g 12.7 g 12.7 g 12.7 g 12.7 g 12.7 g 12.7 g 12.7 g 12.7 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
82715-0107-01 82715-107-01 Main listing 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-02 82715-107-02 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-03 82715-107-03 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-04 82715-107-04 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-05 82715-107-05 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-06 82715-107-06 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-07 82715-107-07 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-08 82715-107-08 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-09 You're viewing this 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active
82715-0107-10 82715-107-10 1 CONTAINER in 1 CARTON / 12.7 g in 1 CONTAINER 2022-07-22 Apr 30, 2029 Active

Pack size FAQ

What quantity is in this package?
This package contains 12.7 g — 1 container in 1 carton / 12.7 g in 1 container.
How does this package differ from NDC 82715-0107-01?
Both are GR LONGSTAY Matte Face Powder SPF 15 Octinoxate 1.995 g/100g Powder — the drug itself is identical. This page's package is the 12.7 g one, while NDC 82715-0107-01 is the 12.7 g package.
What NDC number is used to bill for this package of GR LONGSTAY Matte Face Powder SPF 15 Octinoxate 1.995 g/100g Powder?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GOLDEN ROSE CORRECT AND CONCEAL Concealer Cream Palette 1.995 g/100g 82715-0120-01 ERKUL 2 g — — FDA listed —
GR LONGSTAY Matte Face Powder SPF 15 1.995 g/100gthis 82715-0107-09 ERKUL 12.7 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jul 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 344S277G0Z
    Allantoin is a naturally derived compound that helps soften and soothe skin. In medicines, it works as a skin-conditioning agent and may help support wound healing and reduce irritation in topical formulations.
  • UNII 5QB0T2IUN0
    Aluminum hydroxide is a white powder mineral compound used as an antacid ingredient in some formulations. It works as a buffer and pH regulator to help neutralize stomach acid in the medicine.
  • UNII 1NKX3648J9
    A synthetic antimicrobial compound used as a preservative in medicines and topical products to prevent bacterial and fungal growth, helping keep the medication safe and effective during storage.
  • UNII QBS8A3XZGQ
    A synthetic oil made from diisostearyl alcohol and malic acid. It serves as an emollient and solvent in formulations, helping to dissolve and deliver active ingredients while improving texture and spreadability.
  • UNII 92RU3N3Y1O
    Dimethicone is a silicone-based oil that acts as an anti-foaming agent and lubricant in medicines. It reduces gas bubbles in liquid formulations and helps coat and protect the stomach lining when ingested.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 4CG9F9W01Q
    A synthetic fatty acid ester used as an emollient and skin-conditioning agent in topical medicines. It helps soften the product texture and improves how it spreads and absorbs into the skin.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII V8A1AW0880
    Mica is a naturally occurring mineral that's ground into fine powder. It's used in medicines as a colorant and anti-caking agent to improve appearance and prevent clumping in tablets or powders.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII Z47NNT4J11
    A synthetic plastic polymer used as a film-coating material on tablets and capsules. It helps protect the medicine, control how fast it dissolves, and improve appearance by creating a smooth, glossy outer layer.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII LDC331P08E
    A silicone-based compound that acts as a glidant and flow agent in solid medications. It reduces friction between powder particles, helping the medicine flow smoothly during manufacturing and tablet compression.
  • UNII H92E6QA4FV
    Zinc stearate is a fine white powder made from zinc and stearic acid. It works as a lubricant and glidant to help the tablet or capsule move smoothly through manufacturing equipment and prevents sticking.

18 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesTalc, Dimethicone, Silica, Polymethyl Methacrylate, Zinc Stearate, Diisostearyl Malate, Hexyl Laurate, Triethoxycaprylylsilane, Aluminum Hydroxide, Titanium Dioxide, Phenoxyethanol, Allantoin, Dichlorobenzyl Alcohol, Magnesium Stearate, *Mica, *Iron Oxodes. *contains one or more of these ingredients.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code82715
First marketedJul 2022
Product typeHuman Otc Drug
Portfolio20 products on file

More NDCs from ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI labeler code 82715

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 32 words ▾

Uses • helps prevent sunburn • if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

⏱️ Dosage and Administration 114 words ▾

Directions • apply generously 15 minutes before the sun exposure • apply to cleansed skin • can be applied two coats to increase coverage • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a sun Broad Spectrum SPF value of 15 or higher and other protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. • wear long-sleeved shirts, pants, hats, and sunglasses. • children under 6 months of age: Ask a doctor

⚠️ Warnings 57 words ▾

Warnings For external use only Do not use • on damaged or broken skin When using this product • keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if • rash occurs Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 22 words ▾

Other information • protect the product in this container from excessive heat and direct sun. • store at room temperatures: 15°C- 30°C.

🧪 Active Ingredient 5 words ▾

Active ingredients Octinoxate 1.995% w/v

🧪 Inactive Ingredients 34 words ▾

Inactive ingredients Talc, Dimethicone, Silica, Polymethyl Methacrylate, Zinc Stearate, Diisostearyl Malate, Hexyl Laurate, Triethoxycaprylylsilane, Aluminum Hydroxide, Titanium Dioxide, Phenoxyethanol, Allantoin, Dichlorobenzyl Alcohol, Magnesium Stearate, *Mica, *Iron Oxodes. *contains one or more of these ingredients.

🎯 Purpose 3 words ▾

Purpose Sun Screen

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 2 words ▾

Packaging ERKUL-107

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for GR LONGSTAY Matte Face Powder SPF 15 (this brand).

Top reported reactions

Diverticulitis7
Anaphylactic Reaction6
Bronchiectasis6
Bursitis6
Diverticulum Intestinal6
Hypersensitivity6
Hyperthyroidism6

Age at onset

Adult1

Reporter sex

8 reports
Male · 29%
Female · 71%

Serious outcomes

Life-threatening4
Hospitalization1
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 5 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI has reported a marketing end date of 2029-04-30, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 9 other package presentations of this same product, including 12.7 g (82715-0107-01), 12.7 g (82715-0107-02), 12.7 g (82715-0107-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 82715-0106-01 · ERKUL 82715-0108-01 · ERKUL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.